Choreo LLC’s Twist Bioscience TWST Stock Holding History

Choreo LLC’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$717K	Sell	6,969 -1,852	-21%	-$121K	0.01%	801
2026 Q1	$419K	Buy	+8,821	New	+$395K	0.01%	1040

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Choreo LLC's TWST Position: Q2 2026 in Review

Choreo LLC reduced its Twist Bioscience (TWST) stake by 21% in Q2 2026, selling an estimated $121K and leaving 6,969 shares worth $717K. The position accounts for 0.01% of the portfolio, ranked #801.

Choreo LLC first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Choreo LLC held 6,969 shares of Twist Bioscience worth $717K as of Q2 2026.
Choreo LLC sold 1,852 Twist Bioscience shares in Q2 2026, an estimated $121K.
Twist Bioscience made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #801 holding.
Choreo LLC first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.